Brief: Biora Therapeutics Inc Reports Net Loss Per Share Was $1.64 For Three Months Ended December 31, 2022
March 30 (Reuters) - Biora Therapeutics Inc BIOR.O :
* BIORA THERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS
FOURTH
QUARTER AND FULL-YEAR 2022 FINANCIAL RESULTS
* BIORA THERAPEUTICS INC- NET LOSS PER SHARE WAS $1.64 FOR
THREE
MONTHS ENDED DECEMBER 31, 2022
Source text for Eikon: ID:nGNX5KQTlK
Further company coverage: BIOR.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Biora Therapeutics
See all newsBiora Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Biora Therapeutics Provides Corporate Update And Reports Third Quarter 2024 Financial Results
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Brief: Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules